ESCMID Global
Membership Organizations · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Aeschenvorstadt 55, Basel, Basel-City, 4...Phone Number
+41 615080172Website
www.escmid.orgRevenue
$10.5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About ESCMID Global
ESCMID is dedicated to advancing the field of clinical microbiology and infectious diseases through education, research, and collaboration. The society offers various membership options, educational courses, and events such as the ESCMID Global conference, aimed at professionals in the medical field. Their initiatives include guidelines development, study groups, and support for emerging infections and antimicrobial resistance. ESCMID serves a diverse clientele, including healthcare professionals, researchers, and trainees in the field of infectious diseases.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ESCMID Global your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if ESCMID Global is spiking on competitors!
ESCMID Global, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at ESCMID Global
Click to see if ESCMID Global had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if ESCMID Global has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when ESCMID Global launches new products
Funding: Get notified immidiatlly once ESCMID Global has new funding data
Earning: See what the market has to say on ESCMID Global recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at ESCMID Global
Find more new buyers
Company Profile Activity
Activity Insights
ESCMID Global is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
ESCMID Global is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about ESCMID Global.
ESCMID Global Tech Stack
Most Recent Scoops
Hiring Plans
ESCMID Global has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
ESCMID Global has more open roles in Medical & Health than it has had at any time in the past 12 months with an increased focus that include Microbiology, Medical Microbiology, Public Health, and Epidemiology, and experience with Disease Surveillance, Bioinformatics, and Biostatistics.
Hiring Plans
Hiring Plans
ESCMID Global has more open roles in Medical & Health than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
ESCMID Global has more open roles in Infectious Disease than it has had at any time in the past 12 months.
Hiring Plans
ESCMID Global News & Media
Seegene's CURECA(TM) Emerges as a Potential Game Changer in End-to-End PCR Automation
Seegene previews a concept video of CURECATM at ESCMID Global 2025, ahead of its anticipated debut in July With a fully modular design, CURECATM introduces a bold vision for automating pre-treatment across diverse PCR specimen types Developed for future integration into unattended workflows and adaptable laboratory settings SEOUL, South Korea, May 2, 2025 /PRNewswire/ -- Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, has attracted strong interest after the company presenLonghorn Vaccines and Diagnostics to Present Data on Single and Dual Peptide Universal Influenza Candidates at ESCMID 2025
BETHESDA, Md. & GAITHERSBURG, Md.--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics, a One Health company developing treatments and diagnostic tools for global public health and zoonosis concerns, will present new data from universal influenza pipeline candidates during two poster sessions at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 2025. Longhorn will also be available at booth C108 in Hall B to discuss its differentiated approach to theSCYNEXIS to Present Preclinical Data on Second Generation IV/Oral Fungerp SCY-247 at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
JERSEY CITY, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced the presentation of preclinical efficacy data on its second-generation fungerp candidate SCY-247 at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global) in Vienna, Austria being held from April 11-15, 2025.Enanta Pharmaceuticals Announces Respiratory Syncytial Virus Data Presentation at ESCMID Global 2025
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals Announces Respiratory Syncytial Virus Data Presentation at ESCMID Global 2025
Read more news
Top Membership Organizations Companies
Frequently Asked Questions Regarding ESCMID Global
Sign Up For FreeTo access detailed company insights
ESCMID is dedicated to advancing the field of clinical microbiology and infectious diseases through education, research, and collaboration. The society offers various membership options, educational courses, and events such as the ESCMID Global conference, aimed at professionals in the medical field. Their initiatives include guidelines development... Read More
